Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • CitedCited
European Science Editing 46: e54172
doi: 10.3897/ese.2020.e54172
Received: 14 May 2020 | Approved: 18 Jun 2020 | Published: 24 Aug 2020
This article is part of:
European Science Editing 46
Authors
Barbara DeCastro - Corresponding author
GlaxoSmithKline, Collegeville, United States of America
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Anna Geraci
International Society for Medical Publication Professionals, Tarrytown, United States of America
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Jayme Trott
Janssen Global Services, LLC, Raritan, United States of America
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
G. Peter Snyder
AstraZeneca, Gaithersburg, United States of America
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Yaswant Dayaram
Bayer HealthCare Pharmaceuticals, Whippany, United States of America
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Academic editor
Joan Marsh
The Lancet/Elsevier, London, United Kingdom
https://orcid.org/0000-0002-3494-9324
Articles by the Editor in:  CrossRef  |  PubMed  |  Google Scholar
Author contributions
Barbara DeCastro, Anna Geraci, Jayme Trott, G. Peter Snyder, and Yaswant Dayaram contributed to the data analysis/interpretation and revision of this work, and each has approved the final version of this manuscript. The authors agree to be accountable for all aspects of this work.
Conflict of interest
All authors serve as MPIP Steering Committee members. BDC is an employee and shareholder of GlaxoSmithKline. AG is an employee of the International Society for Medical Publication Professionals. JT is an employee and shareholder of Johnson & Johnson. GPS is an employee and stockholder of AstraZeneca. YD is an employee and shareholder of Bayer.
Supporting agencies
Financial support for the manuscript was provided by Medical Publishing Insights & Practices (MPIP), which is funded by Amgen, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Global Services, LLC (an Operating Company of Johnson & Johnson), Merck, and Pfizer. The authors of this article participated on behalf of MPIP, rather than their employers. The sponsor companies had no direct involvement in the preparation of the article, and the views expressed are solely those of the authors.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Subscribe to email alerts for current Article's categories
Powered by